KEQU
KEQU
NASDAQ · Health Care

Kewaunee Scientific Cp

$34.32
-0.47 (-1.35%)
As of Mar 29, 10:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
236.48M
Net Income
11.22M
Gross Margin
28.6%
Profit Margin
4.7%
Rev Growth
+12.5%
D/E Ratio
1.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.6% 28.6% 50.5% 50.5%
Operating Margin 7.4% 6.7% 10.7% 9.9%
Profit Margin 4.7% 4.5% 9.0% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 236.48M 210.20M 59.81M 50.24M
Gross Profit 67.70M 60.18M 30.19M 25.36M
Operating Income 17.48M 13.98M 6.40M 4.98M
Net Income 11.22M 8.97M 5.37M 4.75M
Gross Margin 28.6% 28.6% 50.5% 50.5%
Operating Margin 7.4% 6.7% 10.7% 9.9%
Profit Margin 4.7% 4.5% 9.0% 9.5%
Rev Growth +12.5% +12.5% +13.1% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.13M 25.13M 32.14M 29.26M
Total Equity 24.73M 24.73M 76.20M 84.12M
D/E Ratio 1.02 1.02 0.42 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 22.38M 18.90M 8.28M 7.47M
Free Cash Flow 3.50M 3.36M